Cargando…
Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results
BACKGROUND: Blockade of the lectin‐like oxidized low‐density lipoprotein receptor‐1 (LOX‐1) is a potentially attractive mechanism for lowering inflammatory and lipid risk in patients with atherosclerosis. This study aims to assess the safety, tolerability, and target engagement of MEDI6570, a high‐a...
Autores principales: | Vavere, Andrea L., Sinsakul, Marvin, Ongstad, Emily L., Yang, Ye, Varma, Vijayalakshmi, Jones, Christopher, Goodman, Joanne, Dubois, Vincent F. S., Quartino, Angelica L., Karathanasis, Sotirios K., Abuhatzira, Liron, Collén, Anna, Antoniades, Charalambos, Koren, Michael J., Gupta, Ruchi, George, Richard T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973634/ https://www.ncbi.nlm.nih.gov/pubmed/36688371 http://dx.doi.org/10.1161/JAHA.122.027540 |
Ejemplares similares
-
MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport
por: George, Richard T., et al.
Publicado: (2021) -
High Plasma Levels of Soluble Lectin‐like Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity
por: Stinson, Sara E., et al.
Publicado: (2023) -
Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1
por: Mentrup, Torben, et al.
Publicado: (2021) -
Small cell lung cancer growth is inhibited by miR-342 through its effect of the target gene IA-2
por: Xu, Huanyu, et al.
Publicado: (2016) -
Life-Threatening Hypocalcemia following Subtotal Parathyroidectomy in a Patient with Renal Failure and Previous Roux-en-Y Gastric Bypass Surgery
por: Palal, Betsy, et al.
Publicado: (2011)